In a World Starved for Coronavirus Vaccines, This Stock Could Double, Says Analyst

At last report, the population of the world totaled some 7.8 billion souls. With COVID-19 continuing to run rampant — indeed, a “second wave” of infections is already starting to swamp health care facilities in France, Spain, and perhaps also the UK — and most potential vaccines against the coronavirus requiring two shots for complete effectiveness, this means there’s an immediate need for more than 15 billion doses of vaccine.Now… who’s going to make all those doses?B. Riley FBR analyst Mayank Mamtani makes the case that Novavax (NVAX) has an important role to play in this fight against coronavirus, even …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.